Beverly Hills Private Wealth, LLC Verona Pharma PLC Transaction History
Beverly Hills Private Wealth, LLC
- $495 Billion
- Q4 2024
A detailed history of Beverly Hills Private Wealth, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Beverly Hills Private Wealth, LLC holds 5,566 shares of VRNA stock, worth $343,255. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,566Holding current value
$343,255% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
208Shares Held
73.3MCall Options Held
1.53MPut Options Held
702K-
Perceptive Advisors LLC New York, NY6.39MShares$394 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$344 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$209 Million5.24% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$193 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$193 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.76B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...